Clinical Trial Update: Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System [NA]

View source ↗

Summary

An update on a post-approval clinical study evaluating the LIPOSORBER LA-15 lipoprotein apheresis system for drug-resistant adult and pediatric primary focal se…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Focal Segmental Glomerulosclerosis

Drugs mentioned

• LIPOSORBER LA-15 System

Snippet

Sponsor: Kaneka Medical America LLC | Conditions: Focal Segmental Glomerulosclerosis | NA | Status: RECRUITING